346 related articles for article (PubMed ID: 30459402)
1. Serum asprosin levels and bariatric surgery outcomes in obese adults.
Wang CY; Lin TA; Liu KH; Liao CH; Liu YY; Wu VC; Wen MS; Yeh TS
Int J Obes (Lond); 2019 May; 43(5):1019-1025. PubMed ID: 30459402
[TBL] [Abstract][Full Text] [Related]
2. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride.
Zhang L; Chen C; Zhou N; Fu Y; Cheng X
Clin Chim Acta; 2019 Feb; 489():183-188. PubMed ID: 29104036
[TBL] [Abstract][Full Text] [Related]
3. Decreased Circulating Levels of Asprosin in Obese Children.
Long W; Xie X; Du C; Zhao Y; Zhang C; Zhan D; Li Z; Ning Q; Luo X
Horm Res Paediatr; 2019; 91(4):271-277. PubMed ID: 31212299
[TBL] [Abstract][Full Text] [Related]
4. Energy Regulation Mechanism and Therapeutic Potential of Asprosin.
Hoffmann JG; Xie W; Chopra AR
Diabetes; 2020 Apr; 69(4):559-566. PubMed ID: 32198197
[TBL] [Abstract][Full Text] [Related]
5. Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome.
Alan M; Gurlek B; Yilmaz A; Aksit M; Aslanipour B; Gulhan I; Mehmet C; Taner CE
Gynecol Endocrinol; 2019 Mar; 35(3):220-223. PubMed ID: 30325247
[TBL] [Abstract][Full Text] [Related]
6. Effects of bariatric surgery in different obesity phenotypes: Tehran Obesity Treatment Study (TOTS).
Barzin M; Aryannezhad S; Khalaj A; Mahdavi M; Valizadeh M; Ghareh S; Azizi F; Hosseinpanah F
Obes Surg; 2020 Feb; 30(2):461-469. PubMed ID: 31650407
[TBL] [Abstract][Full Text] [Related]
7. Asprosin, a Fasting-Induced Glucogenic Protein Hormone.
Romere C; Duerrschmid C; Bournat J; Constable P; Jain M; Xia F; Saha PK; Del Solar M; Zhu B; York B; Sarkar P; Rendon DA; Gaber MW; LeMaire SA; Coselli JS; Milewicz DM; Sutton VR; Butte NF; Moore DD; Chopra AR
Cell; 2016 Apr; 165(3):566-79. PubMed ID: 27087445
[TBL] [Abstract][Full Text] [Related]
8. Evening chronotype associates with obesity in severely obese subjects: interaction with CLOCK 3111T/C.
Ruiz-Lozano T; Vidal J; de Hollanda A; Canteras M; Garaulet M; Izquierdo-Pulido M
Int J Obes (Lond); 2016 Oct; 40(10):1550-1557. PubMed ID: 27339606
[TBL] [Abstract][Full Text] [Related]
9. Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases.
Li X; Liao M; Shen R; Zhang L; Hu H; Wu J; Wang X; Qu H; Guo S; Long M; Zheng H
Mediators Inflamm; 2018; 2018():7375294. PubMed ID: 30524197
[TBL] [Abstract][Full Text] [Related]
10. Effect of Weight Loss after Bariatric Surgery on Thyroid-Stimulating Hormone Levels in Euthyroid Patients with Morbid Obesity.
Juiz-Valiña P; Outeiriño-Blanco E; Pértega S; Varela-Rodriguez BM; García-Brao MJ; Mena E; Pena-Bello L; Cordido M; Sangiao-Alvarellos S; Cordido F
Nutrients; 2019 May; 11(5):. PubMed ID: 31137484
[TBL] [Abstract][Full Text] [Related]
11. Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion.
Wang Y; Qu H; Xiong X; Qiu Y; Liao Y; Chen Y; Zheng Y; Zheng H
Mediators Inflamm; 2018; 2018():9471583. PubMed ID: 29743813
[TBL] [Abstract][Full Text] [Related]
12. Serum Asprosin Concentrations Are Increased and Associated with Insulin Resistance in Children with Obesity.
Wang M; Yin C; Wang L; Liu Y; Li H; Li M; Yi X; Xiao Y
Ann Nutr Metab; 2019; 75(4):205-212. PubMed ID: 31775140
[TBL] [Abstract][Full Text] [Related]
13. Increased serum circulating asprosin levels in children with obesity.
Sünnetçi Silistre E; Hatipoğl HU
Pediatr Int; 2020 Apr; 62(4):467-476. PubMed ID: 32003085
[TBL] [Abstract][Full Text] [Related]
14. Bariatric surgery decreased the serum level of an endotoxin-associated marker: lipopolysaccharide-binding protein.
Yang PJ; Lee WJ; Tseng PH; Lee PH; Lin MT; Yang WS
Surg Obes Relat Dis; 2014; 10(6):1182-7. PubMed ID: 24713521
[TBL] [Abstract][Full Text] [Related]
15. Circulating Asprosin Concentrations in Patients with Obesity and Carbohydrate Disturbances.
Nedeva IS; Assyov Y; Karamfilova V; Vodenicharov V; Gerganova A; Hristova J; Kamenov Z
Horm Metab Res; 2023 Apr; 55(4):284-289. PubMed ID: 36773601
[TBL] [Abstract][Full Text] [Related]
16. Bariatric surgery reduces risk factors for development of type 2 diabetes mellitus in morbidly obese, nondiabetic patients.
Nestvold TK; Nielsen EW; Lappegård KT
Metab Syndr Relat Disord; 2013 Dec; 11(6):441-6. PubMed ID: 24044780
[TBL] [Abstract][Full Text] [Related]
17. Telomere length increase after weight loss induced by bariatric surgery: results from a 10 year prospective study.
Laimer M; Melmer A; Lamina C; Raschenberger J; Adamovski P; Engl J; Ress C; Tschoner A; Gelsinger C; Mair L; Kiechl S; Willeit J; Willeit P; Stettler C; Tilg H; Kronenberg F; Ebenbichler C
Int J Obes (Lond); 2016 May; 40(5):773-8. PubMed ID: 26607038
[TBL] [Abstract][Full Text] [Related]
18. Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer.
Couce ME; Cottam D; Esplen J; Schauer P; Burguera B
Obes Surg; 2006 Jul; 16(7):870-8. PubMed ID: 16839485
[TBL] [Abstract][Full Text] [Related]
19. FTO variants are associated with ANGPTL4 abundances and correlated with body weight reduction after bariatric surgery.
Wang CY; Liu KH; Tsai ML; Ho MY; Yeh JK; Hsieh IC; Wen MS; Yeh TS
Obes Res Clin Pract; 2020; 14(3):257-263. PubMed ID: 32507396
[TBL] [Abstract][Full Text] [Related]
20. Modification of cardiometabolic profile in obese diabetic patients after bariatric surgery: changes in cardiovascular risk.
Pujante P; Hellín MD; Fornovi A; Martínez Camblor P; Ferrer M; García-Zafra V; Hernández AM; Frutos MD; Luján-Monpeán J; Tébar J
Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):812-8. PubMed ID: 24773862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
